Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in Chronic Obstructive Pulmonary Disease (COPD)

NCT03028701 is registered in ClinicalTrials.gov with Neutec Ar-Ge San ve Tic A.Ş as lead sponsor.

NCT NCT03028701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Neutec Ar-Ge San ve Tic A.Ş
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
March 31, 2017
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd